Clinical Perspectives on Peptide Safety and Efficacy

Healthcare providers should understand that research peptides are not FDA-approved for clinical use. These compounds exist in a regulatory gray area. While some peptides show promise in research, they lack the rigorous testing required for pharmaceutical approval. Patient safety should always be the top priority.

If patients are interested in peptides, they should have open conversations with their healthcare providers. It's important to understand potential risks, interactions with other medications, and legal considerations. Research peptides should never replace proven treatments without medical supervision.